Back

MOXIE

Official Title

A Phase 3B, Single-Arm, Open-Label Study to Evaluate Bone Mineral Density with Long-Term Use of Relugolix Combination Tablet in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids or Moderate to Severe Pain Associated with Endometriosis

Study Details

The purpose of this study is to characterize changes in bone mineral density during long-term use of the study medication in people with heavy bleeding due to uterine fibroids or pain associated with endometriosis.

Principal Investigator

Dr. David Eisenberg

IRB Number

202401098

Eligibility

1. Participants must be 18 to 50 years of age
2. Participants must be diagnosed with uterine fibroids or endometriosis
3. Participants must not desire pregnancy in the next 4 years

Volunteer Information

For more information about this study, contact Volunteer for Health at:

Back